Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 49,400 | 10,600 | 4,900 | -2,000 | -8,200 |
| Depreciation Amortization | 63,800 | 27,700 | 42,600 | 25,000 | 14,300 |
| Income taxes - deferred | 34,300 | 8,100 | -2,400 | N/A | N/A |
| Accounts receivable | -600 | -3,100 | -3,000 | -2,500 | -1,200 |
| Accounts payable and accrued liabilities | -1,100 | -8,000 | 11,100 | -11,300 | 3,400 |
| Other Working Capital | 10,500 | -26,100 | 16,600 | -17,400 | 5,300 |
| Other Operating Activity | 15,600 | 18,500 | -8,200 | 13,500 | -2,400 |
| Operating Cash Flow | $171,900 | $27,700 | $61,600 | $5,300 | $11,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21,000 | -7,500 | 700 | -300 | -1,600 |
| Sale Of Investment | 200 | 200 | N/A | N/A | N/A |
| Other Investing Activity | 7,100 | 4,500 | 8,700 | 0 | 0 |
| Investing Cash Flow | $-13,700 | $-2,800 | $9,400 | $-300 | $-1,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -240,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 155,300 | N/A | N/A | N/A | N/A |
| Debt Repayment | -201,700 | -900 | -13,200 | -7,900 | -4,900 |
| Common Stock Issued | 315,900 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 18,500 | 124,500 | 34,700 | 800 | -4,300 |
| Financing Cash Flow | $48,000 | $123,600 | $21,500 | $-7,100 | $-9,200 |
| Beginning Cash Position | 68,100 | 68,100 | N/A | 7,000 | 7,000 |
| End Cash Position | 274,300 | 216,600 | 68,000 | 4,900 | 7,400 |
| Net Cash Flow | $206,200 | $148,500 | $68,000 | $-2,100 | $400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 171,900 | 27,700 | 61,600 | 5,300 | 11,200 |
| Capital Expenditure | -30,700 | -15,100 | -20,800 | -5,800 | -3,300 |
| Free Cash Flow | 141,200 | 12,600 | 40,800 | -500 | 7,900 |